维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="ZUGMAIER G"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase II trial of the anti - CD19 bispecific T cell - engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B - precursor acute lymphoblas- tic leukemia 显示文摘	Topp M Gokbuget N Zugmaier G	2014	J Clin Oncol2014，32，36：	1
2	Tumor growth dependent on kaposi's sarcoma-derived fibroblast growth factor inhibited by pentosan polysulfate显示文摘	Wellstein A Zugmaier G Califano JA	1991	J Natl Cancerlnst1991，83，10：	1
3	Completeremission after blinatumomab-induced donor T-cell activation inthree pediatric patients with post-transplant relapsed acutelymphoblastic leukemia 显示文摘	Handgretinger R Zugmaier G Henze G	2011	Leukemia2011，25，：	1
4	Tumor regression incancer patients by very low doses of a T cell-engaging antibody显示文摘	Bargou R Leo E Zugmaier G	2008	Science2008，321，5891：	1
5	Cytological and molecularremissions with blinatumomab teatment in second or later bonemarrow relapse in pediatric acute lymphpoblastic leukemia ( ALL)显示文摘	Gore L Zugmaier G Henze G	2013	J Clin Oncol2013，31，10：	1
6	Long-term follow-up of hematologic relapse-free survival in a phase 2 study ofblinatumomab in patients with MRD in B-Iineage ALL显示文摘	Topp MS Gokbuget N Zugmaier G	2012	Blood2012，120，26：	1
7	Immunopharmacologicresponse of patients with B-Iineage acute lymphoblastic leukemiato continuous infusion of T cell-engaging CDl 9 /CD3-bispecific BiTE antibody blinatumomab显示文摘	Klinger M Brandi C Zugmaier G	2012	Blood2012，119，26：	1
8	Completeremission after blinatumomab-induced donor T-cell activation inthree pediatric patients with post-transplant relapsed acute lymphoblastic leukemia显示文摘	Handgretinger R Zugmaier G Henze G	2011	Leukemia2011，25，1：	1
9	Complete remission after blinatumomab-indueod donor T-cell activation in three podiatric patients with post-transplant relapsed acute lymphoblastic leukemia显示文摘	Handgretinger R Zugmaier G Henze G	2011	Leukemia2011，25，1：	1
10	Long-term follow-upof hematologic relapse-free survival in a phase 2 study of hlinatumomabin patients with MRD in B-lineage ALL 显示文摘	TOPP MS GOKBUGET N ZUGMAIER G	2012	Blood2012，120，26：	1
11	Phase II trial of theanti-CD19 bispecific T cell-engager blinatumomab showshe- matologic and molecular remissions in patients with relapsedor re- fractory B-precursor acute lymphoblastic leukemia 显示文摘	TOPP MS GOKBUGET N ZUGMAIER G	2014	J Clin Oncol2014，32，36：	1
12	Long-term follow-up of hematologic relapse-free survival in a phase 2 study of blinatumomab in patients with MRD in B-lineage ALL显示文摘	Topp MS Gkbuget N Zugmaier G	2012	Blood2012，120，26：	1
13	Long-term follow-up of serum immunoglobulin levels in blinatumomab-treated patients with minimal residual disease-positive B-precursor acute lymphoblastic leukemia显示文摘	Zugmaier G Topp MS Alekar S	2014	Blood Cancer J2014，4，：	1
14	Pediatric posttransplant relapsed/refractory B-precursor acute lymphoblastic leukemia shows durable remission by therapy with the T-cell engaging bispecific antibody blinatumomab显示文摘	Schlegel P Lang P Zugmaier G	2014	Haematologica2014，99，7：	1
15	Tumor regression in cancer patients by very low doses of a T cell-engaging antibody显示文摘	Bargou R Leo E Zugmaier G		0，，5891：	1
16	Clinical activity of the anti-CD19 bite (R) blinatumomab in patients with relapsed/refractory B-precursor acute lymphoblastic leukemia (ALL):Interim results of a phase II study显示文摘	Topp M S Goekbuget N Zugmaier G		0，，：	1
17	Phase lI trial of the anti-CD19 bispecificT cell-engager blinatumomab shows hematologic and molecular remissions in patients with relapsed or refractory B-precursor acute lymphoblastic leukemia 显示文摘	Topp MS Gfkbuget N Zugmaier G	2014	J Clin Oncol2014，32，36：	1
18	Complete remission after blinatumomabinduced donor T-cell activation in three pediatric patients with posttransplant relapsed acute lymphoblastic leukemia 显示文摘	HANDC-RETINGER R ZUGMAIER G HENZE G	2011	Leukemia2011，25，：	1
19	Clinical activity of the anti CD19 BITE blinatumomab in patients with relapsed/refractory B-precursor acute lym phoblastic leukemia: interim results of a phase 2 study 显示文摘	TOPP M GOEKBUGET N ZUGMAIER G	2011	Haematologiea2011，，：	1
20	Inhibition by pentosan polysulfate (PPS) of heparin-binding growth factors released from tumor cells and blockage by PPS of tumor growth in animals 显示文摘	Zugmaier G Lippman M E Wellstein A	1992	J Natl Cancer Ins1992，84，：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示